Phloretin in Benign Prostate Hyperplasia and Prostate Cancer: A Contemporary Systematic Review

Currently, medication for benign prostate hyperplasia (BPH) and prostate cancer (PCa) are mainly based on modulating the hormone and nervous systems. However, side effects often affect patients, and might decrease their commitment to continuing the medication and lower their quality of life. Some st...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Che-Hsueh, Ou, Yen-Chuan, Lin, Chi-Chien, Lin, Yi-Sheng, Tung, Min-Che, Yu, Chia-Cheng, Lin, Jen-Tai, Wen, Chen-Yueh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322491/
https://www.ncbi.nlm.nih.gov/pubmed/35888117
http://dx.doi.org/10.3390/life12071029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322491/
https://www.ncbi.nlm.nih.gov/pubmed/35888117
http://dx.doi.org/10.3390/life12071029

Ejemplares similares